Reduction in Kawasaki Disease After Nonpharmaceutical Interventions in the COVID-19 Era: A Nationwide Observational Study in Korea.
作者信息
Kang Ji-Man, Kim Young-Eun, Huh Kyungmin, Hong Jinwook, Kim Dong Wook, Kim Min Young, Jung Se Yong, Kim Jong-Hun, Jung Jaehun, Ahn Jong Gyun
机构信息
Department of Pediatrics, Severance Children's Hospital (J.-M.K., M.Y.K., J.G.A.), Yonsei University College of Medicine, Seoul, South Korea.
Institute for Immunology and Immunological Diseases (J.-M.K., M.Y.K., J.G.A.), Yonsei University College of Medicine, Seoul, South Korea.
出版信息
Circulation. 2021 Jun 22;143(25):2508-2510. doi: 10.1161/CIRCULATIONAHA.121.054785. Epub 2021 Jun 7.
Abstract
摘要
相似文献
1
Reduction in Kawasaki Disease After Nonpharmaceutical Interventions in the COVID-19 Era: A Nationwide Observational Study in Korea.新冠疫情时代非药物干预后川崎病发病率的下降：韩国一项全国性观察性研究
Circulation. 2021 Jun 22;143(25):2508-2510. doi: 10.1161/CIRCULATIONAHA.121.054785. Epub 2021 Jun 7.
2
Impact of Social Distancing on Kawasaki Disease-associated Hospitalization, South Korea.社会隔离对韩国川崎病相关住院治疗的影响
Pediatr Infect Dis J. 2021 Oct 1;40(10):e383-e384. doi: 10.1097/INF.0000000000003202.
3
Temporal Correlation Between Kawasaki Disease and Infectious Diseases in South Korea.韩国川崎病与传染病的时间相关性。
JAMA Netw Open. 2022 Feb 1;5(2):e2147363. doi: 10.1001/jamanetworkopen.2021.47363.
4
Prevalence and characteristics of Kawasaki disease before and during the COVID-19 pandemic.新冠疫情之前及期间川崎病的患病率和特征
World J Pediatr. 2021 Apr;17(2):215-217. doi: 10.1007/s12519-021-00412-5. Epub 2021 Feb 6.
5
Kawasaki Disease During COVID-19 Pandemic in Korea - Data Were Added but Are Needed More.韩国新冠疫情期间的川崎病——数据有所增加，但仍需更多数据。
J Korean Med Sci. 2022 May 23;37(20):e170. doi: 10.3346/jkms.2022.37.e170.
6
Epidemiologic features of Kawasaki disease in South Korea: data from nationwide survey, 2009-2011.韩国川崎病的流行病学特征：2009 - 2011年全国性调查数据
Pediatr Infect Dis J. 2014 Jan;33(1):24-7. doi: 10.1097/INF.0000000000000010.
7
Prevention Measures for COVID-19 and Changes in Kawasaki Disease Incidence.COVID-19 的预防措施与川崎病发病率变化。
J Epidemiol. 2021 Nov 5;31(11):573-580. doi: 10.2188/jea.JE20210132. Epub 2021 Sep 17.
8
Kawasaki disease or Kawasaki-like disease: Influence of SARS-CoV-2 infections in Japan.川崎病或川崎样疾病：日本SARS-CoV-2感染的影响
Acta Paediatr. 2021 Feb;110(2):600-601. doi: 10.1111/apa.15535. Epub 2020 Oct 13.
9
Epidemiological features of Kawasaki disease in Korea, 2006-2008.2006 - 2008年韩国川崎病的流行病学特征
Pediatr Int. 2011 Feb;53(1):36-9. doi: 10.1111/j.1442-200X.2010.03178.x.
10
Kawasaki disease recurrence in the COVID-19 era: a systematic review of the literature.川崎病在 COVID-19 时代的复发：文献系统综述。
Ital J Pediatr. 2021 Apr 19;47(1):95. doi: 10.1186/s13052-021-01041-4.
引用本文的文献
1
Frequency of SARS-CoV-2 antecedent infection in patients with Kawasaki disease.川崎病患者中SARS-CoV-2既往感染的频率。
Nagoya J Med Sci. 2025 Feb;87(1):76-83. doi: 10.18999/nagjms.87.1.76.
2
The Comparative Effectiveness of Intravenous Immunoglobulin and Corticosteroids in Kawasaki Disease: A Nationwide Claim Data Analysis.静脉注射免疫球蛋白和皮质类固醇治疗川崎病的比较效果：一项全国性索赔数据分析
J Clin Med. 2025 Mar 16;14(6):2012. doi: 10.3390/jcm14062012.
3
2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association.《2025年心脏病和中风统计数据：美国心脏协会关于美国和全球数据的报告》
Circulation. 2025 Feb 25;151(8):e41-e660. doi: 10.1161/CIR.0000000000001303. Epub 2025 Jan 27.
4
Kawasaki disease before and during the COVID-19 pandemic: a single-center comparative study in Switzerland.川崎病在 COVID-19 大流行前后：瑞士单中心比较研究。
BMC Pediatr. 2024 Oct 8;24(1):637. doi: 10.1186/s12887-024-05115-0.
5
Overview of childhood vasculitis.儿童血管炎概述。
J Rheum Dis. 2024 Jul 1;31(3):135-142. doi: 10.4078/jrd.2024.0045. Epub 2024 Jun 5.
6
Mycoplasma infection aggravates cardiac involvements in Kawasaki diseases: a retrospective study.支原体感染加重川崎病心脏受累：一项回顾性研究。
Front Immunol. 2024 Jan 17;14:1310134. doi: 10.3389/fimmu.2023.1310134. eCollection 2023.
7
2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association.2024 年心脏病与中风统计数据：美国心脏协会发布的美国和全球数据报告。
Circulation. 2024 Feb 20;149(8):e347-e913. doi: 10.1161/CIR.0000000000001209. Epub 2024 Jan 24.
8
Maternal Serum Folic Acid Levels and Onset of Kawasaki Disease in Offspring During Infancy.母体血清叶酸水平与婴儿期川崎病发病的关系。
JAMA Netw Open. 2023 Dec 1;6(12):e2349942. doi: 10.1001/jamanetworkopen.2023.49942.
9
Nationwide Trends in Non-COVID-19 Infectious Disease Laboratory Tests in the Era of the COVID-19 Pandemic in Korea.韩国 COVID-19 大流行时期非 COVID-19 传染病实验室检测的全国趋势。
J Korean Med Sci. 2023 Dec 4;38(47):e408. doi: 10.3346/jkms.2023.38.e408.
10
Kawasaki Disease Before and During the COVID-19 Pandemic: A Nationwide Population-based Study in the United States.川崎病在 COVID-19 大流行前后：美国的一项全国基于人群的研究。
Pediatr Infect Dis J. 2024 Jan 1;43(1):7-13. doi: 10.1097/INF.0000000000004095. Epub 2023 Sep 7.
本文引用的文献
1
Impact of Nonpharmaceutical Interventions on the Incidence of Respiratory Infections During the Coronavirus Disease 2019 (COVID-19) Outbreak in Korea: A Nationwide Surveillance Study.非药物干预对韩国 2019 年冠状病毒病（COVID-19）爆发期间呼吸道感染发病率的影响：一项全国性监测研究。
Clin Infect Dis. 2021 Apr 8;72(7):e184-e191. doi: 10.1093/cid/ciaa1682.
2
Kawasaki Disease: Global Burden and Genetic Background.川崎病：全球负担与遗传背景
Cardiol Res. 2020 Feb;11(1):9-14. doi: 10.14740/cr993. Epub 2020 Jan 26.
3
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association.川崎病的诊断、治疗和长期管理：美国心脏协会发布的一份面向医疗保健专业人员的科学声明。
Circulation. 2017 Apr 25;135(17):e927-e999. doi: 10.1161/CIR.0000000000000484. Epub 2017 Mar 29.
4
Tropospheric winds from northeastern China carry the etiologic agent of Kawasaki disease from its source to Japan.中国东北地区的对流层风将川崎病的病原体从其源头带到日本。
Proc Natl Acad Sci U S A. 2014 Jun 3;111(22):7952-7. doi: 10.1073/pnas.1400380111. Epub 2014 May 19.
5
Seasonality and temporal clustering of Kawasaki syndrome.川崎病的季节性和时间聚集性。
Epidemiology. 2005 Mar;16(2):220-5. doi: 10.1097/01.ede.0000152901.06689.d4.
Zotero 插件